Skip to main content

Peer Review reports

From: Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer

Original Submission
10 Dec 2020 Submitted Original manuscript
13 May 2021 Reviewed Reviewer Report
14 May 2021 Reviewed Reviewer Report - Beom Seok Ko
25 May 2021 Reviewed Reviewer Report
10 Aug 2021 Author responded Author comments - Fumine Tsukamoto
Resubmission - Version 2
10 Aug 2021 Submitted Manuscript version 2
22 Aug 2021 Reviewed Reviewer Report
2 Sep 2021 Reviewed Reviewer Report
6 Sep 2021 Author responded Author comments - Fumine Tsukamoto
Resubmission - Version 3
6 Sep 2021 Submitted Manuscript version 3
9 Sep 2021 Author responded Author comments - Fumine Tsukamoto
Resubmission - Version 4
9 Sep 2021 Submitted Manuscript version 4
Publishing
13 Sep 2021 Editorially accepted
5 Oct 2021 Article published 10.1186/s12885-021-08778-5

You can find further information about peer review here.

Back to article page